Pfizer is “not sure” that its vaccine will stop the transmission of Covid-19



Health

Short url

https://cdnfr1.img.sputniknews.com/img/07e4/0b/12/1044789885_0:0:3303:1859_1200x675_80_0_0_cad8465d10f3bb59ade5586c12765c15.jpg

Sputnik France

https://cdnfr2.img.sputniknews.com/i/logo.png

https://fr.sputniknews.com/sante/202012041044874708-pfizer-nest-pas-certain-que-son-vaccin-stoppe-la-transmission-du-covid-19/

“This is something that needs to be investigated”: According to the CEO of pharmaceutical giant Pfizer, Albert Bourla, the company still does not know whether those who receive the vaccine against Covid-19 can still transmit the virus.

When the UK became the first country to approve Pfizer’s vaccine, CEO Albert Bourla gave an interview to NBC News detailing the vaccine.

“Even though I got this protection, I still can [le coronavirus, ndlr] pass it on to other people? Asked NBC reporter Lester Holt.

“I think it is something that needs to be looked at,” said the CEO. “We’re not sure what we know yet.”

Criticism of pharmaceutical nationalism

The UK is the first country in the world to approve Pfizer’s vaccine, 40 million doses of which have been purchased. It will be available “next week,” a UK government spokesman said on Wednesday (December 2).

The British government later said that Brexit had enabled the UK to be the first Western country to allow a vaccine. A claim that criticized pharmaceutical nationalism.

95% efficiency

On November 18, US pharmaceutical giant Pfizer and its German partner BioNTech announced that their Covid-19 vaccine candidate is 95% effective.

A dose of Pfizer’s vaccine costs $ 19.50 (about $ 16), so the price of the vaccination per person will be about $ 40 (almost $ 33).




Source link